In this study, for the first time we found that CDC6 expression was increased in DLBCL compared with reactive lymphocytic hyperplasia, CDC6 overexpression was often seen in non-GCB subtype and predicted adverse prognosis in patients with DLBCL. Here, CDC6 is linked to diffuse large B-cell lymphoma.